Clinical Trial Update: A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pridopidine versus placebo for symptomatic treatment in Huntington's disease completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Pridopidine (pridopidine)

Snippet

Sponsor: Prilenia | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-07-19